Bank of Montreal
STRO icon

Bank of Montreal’s Sutro Biopharma STRO Stock Holding History

Bank of Montreal’s Portfolio STRO Stock Details STRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-81,496
Closed -$2.85M – 3920
2024
Q3 		$2.85M Buy
+81,496
New +$3.19M ﹤0.01% 1544
2021
Q2 		– Sell
-96
Closed -$20K – 4817
2021
Q1 		$20K Sell
96
-337
-78% -$80K ﹤0.01% 4066
2020
Q4 		$111K Buy
433
+313
+261% +$51.8K ﹤0.01% 3531
2020
Q3 		$13K Sell
120
-17
-12% -$1.61K ﹤0.01% 4034
2020
Q2 		$12K Buy
+137
New +$13.1K ﹤0.01% 4095
2020
Q1 		– Sell
-209
Closed -$23K – 4668
2019
Q4 		$23K Buy
209
+114
+120% +$11.8K ﹤0.01% 4249
2019
Q3 		$9K Buy
95
+3
+3% +$303 ﹤0.01% 4457
2019
Q2 		$10K Buy
+92
New +$10.1K ﹤0.01% 4535
2019
Q1 		– Hold
0
– – – 4722

Other funds holding STRO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
MC
Merck & Co Kenilworth, New Jersey $349M AUM 146.07% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

Bank of Montreal's STRO Position: Q4 2024 in Review

Bank of Montreal sold out of Sutro Biopharma (STRO) in Q4 2024, closing a stake of 81,496 shares — an estimated $2.85M sold.

Bank of Montreal first reported a position in STRO in Q2 2019 and held it in 8 quarters. The position peaked at $2.85M in Q3 2024. 122 funds tracked by Wall St. Rank hold STRO as of Q4 2024.

  • Bank of Montreal reported no remaining Sutro Biopharma position as of Q4 2024 after selling out during the quarter.
  • Bank of Montreal sold 81,496 Sutro Biopharma shares in Q4 2024, an estimated $2.85M.
  • Bank of Montreal first reported a position in Sutro Biopharma in Q2 2019 and held it in 8 quarters.
  • Bank of Montreal's Sutro Biopharma position peaked at $2.85M in Q3 2024.
  • 122 funds tracked by Wall St. Rank held Sutro Biopharma as of Q4 2024.

Based on Bank of Montreal's 13F filing for Q4 2024, filed 13 Feb 2025.